Overheard with Ajay Raju featuring Dr. David Fajgenbaum | Part 2
Philadelphia -- In this second installment of his conversation with Ajay Raju, Dr. David Fajgenbaum, Penn Medicine physician-scientist and founder of Every Cure, returns to explore what makes Philadelphia's innovation ecosystem tick, and what it will take to keep it thriving.
The conversation opens with a candid look at Philadelphia's post-industrial identity: a city that once led the Industrial Revolution now navigating whether its institutions, particularly Penn Medicine, can anchor a new era of scientific breakthrough the way Boston-Cambridge or Silicon Valley have. Fajgenbaum credits Penn's culture of encouragement, the same environment that let him pursue the research that saved his own life, while acknowledging the investment gaps that still send world-class talent and teams elsewhere.
From there, the discussion turns personal. Fajgenbaum reflects on watching patients he helped save reach milestones he never imagined - weddings, graduations, engagements - and how those moments, more than the science itself, have reshaped his sense of purpose. He shares Every Cure's ambitious five-year goal: repurposing existing drugs to treat 15-25 currently devastating diseases, and explains why proven medicines, not novel compounds, may deliver the fastest path to impact in the AI era.
The episode closes on questions of legacy, mortality, and mentorship, including a moving reflection on his nonprofit AMF, founded in his mother's memory, and what it means to build something built to outlast its founder.
